Market Snapshot

BSE Sensex: 77763.91 0.34%
BSE 500: 36431.45 0.15%
BSE 200: 11317.86 0.17%
BSE 100: 25809.44 0.24%
BSE BANKEX: 65450.3 -0.09%
BSE IT: 26730.46 1.55%
Nifty 50: 24270.85 0.39%
Nifty 500: 23301.15 0.16%
Nifty 200: 13992.05 0.19%
Nifty 100: 25301.9 0.28%
Nifty Midcap 100: 62190.3 -0.19%
Nifty Small 100: 19175.1 0.04%
Nifty IT: 27439.4 1.76%
Nifty PSU Bank: 8407.6 -1.54%

News:

Karur Vysya Banks total busine...
Yes Bank reports 18% YoY rise ...
Godrej Consumer Products expec...
Quality Power arm Mehru Electr...
Bandhan Banks total deposits r...

Syncom Formulations (India) Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

03 Jul 2026 | 03:59 PM

14.23

-0.02 (-0.14%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-25.03%

Return (1Y)

Underperformed BSE Healthcare by 37.31%
More Volatile

2.22%

Standard Deviation (1Y)

Higher than BSE Healthcare by 1.38%
Inconsistent Performer

2/12

Months

underperformed BSE Healthcare
AxisDirect View

No View

52 Week High-Low

19

10

News & Announcements

Syncom Formulations (India) consolidated net profit rises 42.28% in the March 2026 quarter

43 days ago

Syncom Formulations (India) standalone net profit rises 40.40% in the March 2026 quarter

43 days ago

Syncom Formulations (India) schedules board meeting
52 days ago

Syncom Formulations (India) schedules board meeting

14 - May - 2026 12:00 | 52 days ago

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 22 May 2026.
Syncom Formulations (India) consolidated net profit rises 45.46% in the December 2025 quarter
143 days ago

Syncom Formulations (India) consolidated net profit rises 45.46% in the December 2025 quarter

12 - Feb - 2026 12:00 | 143 days ago

Net profit of Syncom Formulations (India) rose 45.46% to Rs 18.91 crore in the quarter ended December 2025 as against Rs 13.00 crore during the previous quarter ended December 2024. Sales declined 9.72% to Rs 115.14 crore in the quarter ended December 2025 as against Rs 127.53 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 115.14 127.53 -10

OPM % 18.42 11.55 -

PBDT 26.45 18.57 42

PBT 25.09 17.26 45

NP 18.91 13.00 45

Powered by Capital Market - Live News

Price vs Volume

1D
5D
1M
3M
1Y
3Y
5Y
MAX

Stock Trivia

FII shareholding in Syncom Formulations (India) Ltd has decreased by -18.16% since past 3 Months
MF shareholding in Syncom Formulations (India) Ltd has increased by 5% since past 3 Months
FII shareholding in Syncom Formulations (India) Ltd has increased by 97.78% since past 1 Year
MF shareholding in Syncom Formulations (India) Ltd has increased by 16.67% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

×

Online trading for clients based in USA and Canada is restricted. You can continue placing orders through mapped dealers offline

OK

vV5.0.0.6-60